11-124920509-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152722.5(HEPACAM):c.*629G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000152 in 1,319,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 30)
Exomes 𝑓: 0.0000015 ( 0 hom. )
Consequence
HEPACAM
NM_152722.5 3_prime_UTR
NM_152722.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.272
Genes affected
HEPN1 (HGNC:34400): (hepatocellular carcinoma, down-regulated 1) This gene is expressed predominantly in the liver. Transient transfection studies show the expression of this gene significantly inhibits cell growth, suggesting a role for this gene in apoptosis. Expression of this gene is down-regulated or lost in hepatocellular carcinomas (HCC), suggesting that loss of this gene is involved in carcinogenesis of hepatocytes (PMID:12971969). This gene maps to the 3'-noncoding region of the HEPACAM gene (GeneID:220296) on the antisense strand. [provided by RefSeq, Aug 2020]
HEPACAM (HGNC:26361): (hepatic and glial cell adhesion molecule) The protein encoded by this gene is a single-pass type I membrane protein that localizes to the cytoplasmic side of the cell membrane. The encoded protein acts as a homodimer and is involved in cell motility and cell-matrix interactions. The expression of this gene is downregulated or undetectable in many cancer cell lines, so this may be a tumor suppressor gene. [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HEPN1 | NM_001037558.4 | c.*492C>T | 3_prime_UTR_variant | 1/1 | ENST00000408930.7 | NP_001032647.2 | ||
HEPACAM | NM_152722.5 | c.*629G>A | 3_prime_UTR_variant | 7/7 | ENST00000298251.5 | NP_689935.2 | ||
LOC107984406 | XR_001748429.3 | n.335-22891C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HEPACAM | ENST00000298251.5 | c.*629G>A | 3_prime_UTR_variant | 7/7 | 1 | NM_152722.5 | ENSP00000298251 | P1 | ||
HEPN1 | ENST00000408930.7 | c.*492C>T | 3_prime_UTR_variant | 1/1 | NM_001037558.4 | ENSP00000386143 | P1 | |||
HEPACAM | ENST00000703807.1 | c.*629G>A | 3_prime_UTR_variant | 7/7 | ENSP00000515485 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
GnomAD3 exomes AF: 0.00000766 AC: 1AN: 130532Hom.: 0 AF XY: 0.0000143 AC XY: 1AN XY: 70120
GnomAD3 exomes
AF:
AC:
1
AN:
130532
Hom.:
AF XY:
AC XY:
1
AN XY:
70120
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000152 AC: 2AN: 1319194Hom.: 0 Cov.: 29 AF XY: 0.00000155 AC XY: 1AN XY: 645662
GnomAD4 exome
AF:
AC:
2
AN:
1319194
Hom.:
Cov.:
29
AF XY:
AC XY:
1
AN XY:
645662
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Megalencephalic leukoencephalopathy with subcortical cysts Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at